HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Medazepam

HCID 4041
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
2898-12-6
Standard SMILES
CN1CCN=C(c2ccccc2)c2cc(Cl)ccc21
InChIKey
YLCXGBZIZBEVPZ-UHFFFAOYSA-N
Molecular formula
C16H15ClN2
Average molar mass
270.75 g/mol
Monoisotopic mass
270.0923762

Overview

Medazepam is an organic molecular entity.

Names & identifiers

Preferred name
Medazepam
IUPAC
7-chloro-1-methyl-5-phenyl-2,3-dihydro-1,4-benzodiazepine
English name
MEDAZEPAM
Molecular formula
C16H15ClN2
Molecular weight
270.76

Names & synonyms

medazepamPamnace2898-12-6MedazepamumDTXSID1048708P0J3387W3SDTXCID80286347-Chloro-1-methyl-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepineRefChem:810832N05BA03Ro 54556Ro 5 4556
Show more names
SimanDiepinElbrusEsmailAnsilanmezapamMezepan
220-783-4ResmitNobriumRudotelEnobrinNiveltonNarsis7-Chloro-2,3-dihydro-1-methyl-5-phenyl-1H-1,4-benzodiazepine

Database identifiers

CAS
2898-12-6
PubChem CID
4041
DTXSID
DTXSID1048708
ChEMBL
CHEMBL28333
ChEBI
CHEBI:31807
UNII
P0J3387W3S
EC Number
220-783-4
Nikkaji
J2.167I

Properties

Computed structural propertiesFilling in

XLogP
4.4
Topological polar surface area
15.6 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
2
Rotatable bonds
1
Heavy atoms
19
Formal charge
0
Complexity
336

Experimental & physicochemical properties

Drugs · 5 items

DEA NFLIS-Drug Category -> Benzodiazepines

DEA Schedule IV Controlled Substance -> Depressants

Pharmaceuticals -> Benzodiazepines

Pharmaceuticals -> Synthetic Cannabinoids or Psychoactive Compounds

Pharmaceuticals

SpringerMaterials PropertiesFusion temperature
LogP3.3
Human DrugsPharmaceuticals
Collision Cross Section160.8 Ų [M+H]+ [CCS Type: TW; Method: Major Mix IMS/Tof Calibration Kit (Waters)]

Physicochemical properties

Melting point
95 · 95-97°
Boiling point
420.36 °C · 420.36°C (rough estimate)
Density
1.1336 · 1.1336 (rough estimate)
refractive index
1.5749 · 1.5749 (estimate)

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P260, P261, P263, P264, P270, P271, P280, P301+P317, P304+P340, P318, P319, P330, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 31 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Regulatory InformationDEA schedule IV controlled substance
Other Safety InformationIMAP assessments - 1H-1,4-Benzodiazepine, 7-chloro-2,3-dihydro-1-methyl-5-phenyl-: Environment tier I assessment
Hazard Classes and CategoriesAcute Tox. 4 (100%)

Toxicology

Treatment · 1 item

General supportive measures should be employed, along with intravenous fluids, and an adequate airway maintained. Hypotension may be combated by the use of norepinephrine or metaraminol. Dialysis is of limited value. Flumazenil (Anexate) is a competitive benzodiazepine receptor antagonist that can be used as an antidote for benzodiazepine overdose. In particular, flumazenil is very effective at reversing the CNS depression associated with benzodiazepines but is less effective at reversing respiratory depression. Its use, however, is controversial as it has numerous contraindications. It is contraindicated in patients who are on long-term benzodiazepines, those who have ingested a substance that lowers the seizure threshold, or in patients who have tachycardia or a history of seizures. As a general rule, medical observation and supportive care are the mainstay of treatment of benzodiazepine overdose. Although benzodiazepines are absorbed by activated charcoal, gastric decontamination with activated charcoal is not beneficial in pure benzodiazepine overdose as the risk of adverse effects often outweigh any potential benefit from the procedure. It is recommended only if benzodiazepines have been taken in combination with other drugs that may benefit from decontamination. Gastric lavage (stomach pumping) or whole bowel irrigation are also not recommended.

Chemistry & industry

Pharmacology

ATC Code · 2 items

N - Nervous system

QN - Nervous system

MeSH Pharmacological Classification · 5 items

Drugs used to prevent SEIZURES or reduce their severity.

Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety.

A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358)

Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here.

Substances that do not act as agonists or antagonists but do affect the GAMMA-AMINOBUTYRIC ACID receptor-ionophore complex. GABA-A receptors (RECEPTORS, GABA-A) appear to have at least three allosteric sites at which modulators act: a site at which BENZODIAZEPINES act by increasing the opening frequency of GAMMA-AMINOBUTYRIC ACID-activated chloride channels; a site at which BARBITURATES act to prolong the duration of channel opening; and a site at which some steroids may act. GENERAL ANESTHETICS probably act at least partly by potentiating GABAergic responses, but they are not included here.

Uses & manufacturing

Use ClassificationPharmaceuticals

Applications

UsesTranquilizer (minor).

Related reactions

6 records
New reaction record
HRID 168647 reaction equation
HRID 168647As product
HRID 262945 reaction equation
HRID 262945As product
HRID 441939 reaction equation
HRID 441939As product
HRID 441940 reaction equation
HRID 441940As product
HRID 1113120 reaction equation
HRID 1113120As product
HRID 1212979 reaction equation
HRID 1212979As product

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
storage temp.
-20 °C · -20°C
solubility
Methanol (Slightly), Water (Slightly)
form
Solid
pka
6.2 · pKa 6.2(H2O) (Uncertain)
color
Yellow to Orange
Water Solubility
10.83 mg/L · 10.83mg/L(37 ºC)
Major Application
clinical testing
InChI
1S/C16H15ClN2.ClH/c1-19-10-9-18-16(12-5-3-2-4-6-12)14-11-13(17)7-8-15(14)19;/h2-8,11H,9-10H2,1H3;1H
InChIKey
XBWAZCLHZCFCGK-UHFFFAOYSA-N
SMILES
Clc1cc2c(cc1)N(CCN=C2c3ccccc3)C.Cl
EWG's Food Scores
1 · 1
FDA UNII
0 J3387W3S · P0J3387W3S
ATC code
5 BA03 · N05BA03
UNSPSC Code
41116107 · 41116107
NACRES
24 · NA.24
Symbol(GHS)
7 · GHS07,GHS08
Signal word
Warning
Hazard statements
336 · H336-H362-H361-H302
Precautionary statements
201 · P201-P260-P263-P264-P270-P308+P313-P201-P202-P281-P308+P313-P405-P501-P264-P270-P301+P312-P330-P501-P261-P271-P304+P340-P312-P403+P233-P405-P501
target organs
Eyes,Central nervous system
Hazard Codes
Xn
Risk Statements
22 · 22
RIDADR
3249 · 3249
WGK Germany
2 · WGK 2
HazardClass
6.1 · 6.1(b)
PackingGroup
III
Storage Class
3 · 3 - Flammable liquids
Hazard Classifications
3 DermalAcute · Acute Tox. 3 DermalAcute Tox. 3 InhalationAcute Tox. 3 OralFlam. Liq. 2STOT SE 1
Toxicity
50 in · LD50 in mice (mg/kg): 360 i.p., 1070 orally (Randall)
DEA Controlled Substances
2836 CSA · CSCN: 2836CSA SCH: Schedule IVNARC: No
Toxicity Summary · 1 item

Benzodiazepines bind nonspecifically to benzodiazepine receptors BNZ1, which mediates sleep, and BNZ2, which affects affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABAA) receptors, this enhances the effects of GABA by increasing GABA affinity for the GABA receptor. Binding of the inhibitory neurotransmitter GABA to the site opens the chloride channel, resulting in a hyperpolarized cell membrane that prevents further excitation of the cell.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).

Safety data

wgk
WGK 2
ridadr
3249
Toxicity
LD50 in mice (mg/kg): 360 i.p., 1070 orally (Randall)
risk_code
22
Signal word
Warning
Symbol(GHS)
GHS07,GHS08
hazard_code
Xn
hazard_class
6.1(b)
Storage Class
3 - Flammable liquids
packing_group
III
target organs
Eyes,Central nervous system
Hazard statements
H336-H362-H361-H302
Hazard Classifications
Acute Tox. 3 DermalAcute Tox. 3 InhalationAcute Tox. 3 OralFlam. Liq. 2STOT SE 1
Precautionary statements
P201-P260-P263-P264-P270-P308+P313-P201-P202-P281-P308+P313-P405-P501-P264-P270-P301+P312-P330-P501-P261-P271-P304+P340-P312-P403+P233-P405-P501
DEA Controlled Substances
CSCN: 2836CSA SCH: Schedule IVNARC: No

Upstream & downstream products

Upstream raw materials

Sodium hydroxide2-Bromoethylamine hydrobromidePhosphorus oxychlorideAcetic anhydrideCalcium carbonateOxalic acid

Additional notes

DefinitionChEBI: Medazepam is an organic molecular entity.